SABCS 2022

December 06-10, 2022
San Antonio, TX

San Antonio Breast Cancer Symposium 2022

Explore more Hematology-Oncology congress materials

Results(1)

Hematology-Oncology

Antitumor Activity of Zanidatamab with Palbociclib and Fulvestrant in HER2+ Hormone-Receptor Positive (HR+) Metastatic Breast Cancer

Author(s): Santiago Escrivá-de-Romani, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

Hematology-Oncology

View Poster

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.